Hannings A, Michaels N, Hiller D, Marciniak M, Ferreri S
Innov Pharm. 2021; 10(3).
PMID: 34007561
PMC: 8127085.
DOI: 10.24926/iip.v10i3.939.
Hudry C, Lebrun A, Moura B, Zinovieva E, Backers O, Herman-Demars H
Rheumatol Ther. 2017; 4(1):183-194.
PMID: 28243967
PMC: 5443726.
DOI: 10.1007/s40744-017-0057-3.
Thakur K, Biberger A, Handrich A, Farouk Rezk M
Rheumatol Ther. 2016; 3(1):77-89.
PMID: 27747519
PMC: 4999586.
DOI: 10.1007/s40744-016-0035-1.
Hyllested-Winge J, Sparre T, Pedersen L
Med Devices (Auckl). 2016; 9:11-8.
PMID: 26793007
PMC: 4708877.
DOI: 10.2147/MDER.S59229.
Ridyard C, Dawoud D, Tuersley L, Hughes D
Patient. 2016; 9(4):281-92.
PMID: 26792584
DOI: 10.1007/s40271-015-0160-x.
Assessing usability, label comprehension, pen robustness and pharmacokinetics of a self-administered prefilled autoinjector pen of methotrexate in patients with rheumatoid arthritis.
Pachon J, Kivitz A, Heuer K, Pichlmeier U
SAGE Open Med. 2016; 2:2050312114564241.
PMID: 26770759
PMC: 4712753.
DOI: 10.1177/2050312114564241.
Usability of the Novel Liraglutide 3.0 mg Pen Injector Among Overweight or Obese Adult Patients With or Without Prior Injection Experience.
Fujioka K, Sparre T, Sun L, Krogsgaard S, Kushner R
J Diabetes Sci Technol. 2015; 10(1):164-74.
PMID: 26183599
PMC: 4738203.
DOI: 10.1177/1932296815593295.
Efficacy of insulin analogues in diabetic patients attending primary care centers.
Bardisi W, Khorsheed M, Magliah F, Magliah A
Saudi Med J. 2015; 36(7):829-33.
PMID: 26108587
PMC: 4503902.
DOI: 10.15537/smj.2015.7.11409.
Safe and Effective Use of the Once Weekly Dulaglutide Single-Dose Pen in Injection-Naïve Patients With Type 2 Diabetes.
Matfin G, Van Brunt K, Zimmermann A, Threlkeld R, Ignaut D
J Diabetes Sci Technol. 2015; 9(5):1071-9.
PMID: 25901022
PMC: 4667342.
DOI: 10.1177/1932296815583059.
Evaluation of the Dual-Chamber Pen Design for the Injection of Exenatide Once Weekly for the Treatment of Type 2 Diabetes.
LaRue S, Malloy J
J Diabetes Sci Technol. 2015; 9(4):815-21.
PMID: 25759181
PMC: 4525643.
DOI: 10.1177/1932296815576186.
Development and validation of the Diabetes Medication System Rating Questionnaire-Short Form.
Peyrot M, Xu Y, Rubin R
Diabet Med. 2014; 31(10):1237-44.
PMID: 24673614
PMC: 4232890.
DOI: 10.1111/dme.12453.
Is the indicator magnifying window for insulin pens helpful for elderly diabetic patients?.
Lee J, Hong E, Ohn J, Cho Y
Diabetes Metab J. 2013; 37(2):149-51.
PMID: 23641356
PMC: 3638226.
DOI: 10.4093/dmj.2013.37.2.149.
Comparison of patient satisfaction with two different etanercept delivery systems. A randomised controlled study in patients with rheumatoid arthritis.
Muller-Ladner U, Flipo R, Vincendon P, Brault Y, Kielar D
Z Rheumatol. 2012; 71(10):890-9.
PMID: 22956167
DOI: 10.1007/s00393-012-1034-4.
Analysis of comparison of patient preference for two insulin injection pen devices in relation to patient dexterity skills.
Antinori-Lent K
J Diabetes Sci Technol. 2012; 6(4):917-20.
PMID: 22920819
PMC: 3440164.
DOI: 10.1177/193229681200600424.
A review of insulin pen devices and use in the elderly diabetic population.
Wright B, Bellone J, McCoy E
Clin Med Insights Endocrinol Diabetes. 2012; 3:53-63.
PMID: 22879787
PMC: 3411523.
DOI: 10.4137/CMED.S5534.
Evaluation of pharmacokinetics, user handling, and tolerability of peginterferon alfa-2a (40 kDa) delivered via a disposable autoinjector device.
Varunok P, Lawitz E, Beavers K, Matusow G, Leong R, Lambert N
Patient Prefer Adherence. 2011; 5:587-99.
PMID: 22163158
PMC: 3234901.
DOI: 10.2147/PPA.S26566.
Comparison of clinically relevant technical attributes of five insulin injection pens.
Asakura T
J Diabetes Sci Technol. 2011; 5(5):1203-9.
PMID: 22027319
PMC: 3208882.
DOI: 10.1177/193229681100500527.
Trend analyses of insulin delivery systems in the United States.
Lee L, Li Q, Reynolds M, Engelman W
J Diabetes Sci Technol. 2011; 5(5):1116-23.
PMID: 22027304
PMC: 3208867.
DOI: 10.1177/193229681100500512.
An open-label, multicenter study to evaluate the safe and effective use of the single-use autoinjector with an Avonex® prefilled syringe in multiple sclerosis subjects.
Phillips J, Fox E, Grainger W, Tuccillo D, Liu S, Deykin A
BMC Neurol. 2011; 11:126.
PMID: 21999176
PMC: 3213083.
DOI: 10.1186/1471-2377-11-126.
Perceived medication benefits and their association with interest in using inhaled insulin in type 2 diabetes: a model of patients' cognitive framework.
Peyrot M, Rubin R
Patient Prefer Adherence. 2011; 5:255-65.
PMID: 21792298
PMC: 3140308.
DOI: 10.2147/PPA.S18799.
